Download MBBS (Bachelor of Medicine, Bachelor of Surgery) 1st Year, 2nd Year, 3rd Year and Final year Surgery 36 Lymphatic System And Its Diseases PPT-Powerpoint Presentations and lecture notes
LYMPHATIC SYSTEM AND ITS
DISEASES
Dept. of Surgery
ANATOMY
A 1-way system that returns lymph via
vessels to the CVS.
Consists of:
Fluid, known as lymph
Vessels that transport lymph
Organs that contain lymphoid tissue (eg,
lymph nodes, spleen, and thymus)
Organ
Function
Lymph
Contains nutrients, oxygen, hormones, and fatty acids, as
well as toxins and cellular waste products, that are
transported to and from cellular tissues
Lymphatic vessels
Transport lymph from peripheral tissues to the veins of the
cardiovascular system
Lymph nodes
Monitors the composition of lymph, the location of pathogen
engulfment and eradication, the immunologic response, and
the regulation site
Spleen
Monitors the composition of blood components, the location
of pathogen engulfment and eradication, the immunologic
response, and the regulation site
Thymus
Serves as the site of T-lymphocyte maturation, development,
and control
Functions are :
Restoration of excess interstitial fluid and
proteins to the blood
Absorption of fats and fat-soluble vitamins from
the digestive system
Defense against invading organisms
LYMPH
Fluid derived from plasma.
Contains nutrients, oxygen, and hormones, as
well as toxins and cellular waste.
This fluid is removed by lymphatic vessels that
pass through lymph nodes.
As the lymph passes through the lymph nodes,
lymphocytes and monocytes enter it.
LYMPHATIC VESSELS
Are blind-ended tubes with thin endothelial
walls.
Coalesce to form larger meshlike vessels.
Eventually form 2 lymphatic ducts: the right
lymphatic duct and the thoracic duct.
Have 1-way valves to prevent any backflow.
LYMPH NODES
Bean-shaped structures
Filter the lymph before it rejoins the blood
stream.
Approximately 600-700, predominantly in the
neck, axillae, groin, mediastinum, and
mesenteries of the GI tract.
Constitute a main line of defense by hosting 2
types of immune protective cell lines, T and B
lymphocytes.
2 distinct regions, the cortex and the medulla.
The cortex contains follicles, which are collections
of lymphocytes.
Center of the follicles is called germinal centers
that has B-lymphocytes while the remaining cells
of the cortex are T-lymphocytes.
Vessels entering the lymph nodes are called
afferent lymphatic vessels and those exiting are
called efferent lymphatic vessels
LYMPHADENOPATHY
ETIOLOGY
Five broad etiologic categories :
An immune response to infective agents (eg,
bacteria, virus, fungus)
Inflammatory cells in infections involving the
lymph node
Metastasis
Malignancy of lymphocytes or macrophages (eg,
leukemia, lymphoma)
Storage disorders
PRESENTATION
Duration
Associated symptoms
Past illnesses, infections, local trauma, or bites.
Constitutional symptoms.
If recurrent infections, HIV must be considered.
Family and social history
PHYSICAL EXAMINATION
Complete general examination.
The skin and the soft tissue drained by the
enlarge node should be carefully examined.
The character of the lymph node should be noted.
Whether the lymphadenopathy is a local or a
general phenomenon.
GENERALIZED LYMPHADENOPATHY:
Upper respiratory tract infections (rhinovirus,
adenovirus, influenzavirus, parainfluenza virus,
respiratory syncytial virus)
Epstein-Barr virus (EBV)
Cytomegalovirus (CMV)
Varicella-zoster virus
Herpes simplex virus
Paramyxovirus
Coxsackieviruses A and B
Echovirus
Enterovirus
Human herpesvirus-6
Human immunodeficiency virus
WORK UP
LABORATORY STUDIES
Perform the least invasive test that provides the
most information.
CBC .
Serum LDH- to determine the turnover rate of
cells in the case of leukemia or lymphoma.
Tuberculin skin test.
Monospot and titers for EBV, CMV, catscratch
disease, or toxoplasmosis
IMAGING STUDIES
Chest radiography to assess for bacterial
pneumonias or tuberculosis, and hilar
adenopathy in the case of malignancy.
Ultrasonography.
CT scan.
18F-FDG PET.
FNAC
BIOPSY
LYMPHEDEMA
?Lymphatic obstruction
?Dec. lymphatic transport
?Stagnation of HMW proteins
? High protein edema
? High oncotic pressure in the interstitium
favors the accumulation of additional water.
? Massive dilatation of lymphatic vessels
? Inflammation
? Shrunken and hard lymph nodes
DERMATOLOGIC PATHOLOGY
The overlying skin becomes thickened and
displays the peau d'orange appearance.
Chronic lymphedema causes fissuring and
impairment of the epidermis, allowing bacteria to
enter and grow, and leading to lymphorrhea, the
leakage of lymph.
With chronic lymphedema, the development of
verrucous, cobblestone plaques, a condition
known as elephantiasis nostra verrucosa (ENV),
can occur.
ETIOLOGY
In primary lymphedema, there is congenital
hypoplasia or aplasia of the peripheral
lymphatics or valvular incompetence.
In secondary lymphedema, the lymphatic
drainage is blocked due to:
Recurrent attacks of lymphangitis
Malignancy
Obesity
Surgery
PRIMARY LYMPHEDEMA
A developmental abnormality of the lymphatic
system.
3 main types, distinguished by their age of onset:
1. Congenital lymphedema (Milroy disease)
2. Lymphedema praecox (Meige disease)
3. Lymphedema tarda
Involve the lower extremities almost exclusively.
CONGENITAL LYMPHEDEMA
10-25% of all primary lymphedema cases.
Autosomal-dominant.
Anaplastic lymphatic channels.
Manifests at birth or later, up to age 1 year.
F:M= 2:1.
LL:UL= 3:1
The edema is most commonly pitting and non
painful.
2/3 rd of patients have bilateral lymphedema.
May improve spontaneously with increasing age.
LYMPHEDEMA PRAECOX
Most common form of primary lymphedema (65-
80%).
Becomes clinically evident after birth and before
age 35 years.
F:M= 4:1
About 70% of cases are U\L.
A hypoplastic pattern, with the lymphatics
reduced in caliber and number.
LYMPHEDEMA TARDA
Manifests later in life, usually in persons older
than 35 years.
Caused by a defect in the lymphatic valves,
resulting in incompetent valve function.
Accounts for only 10% of cases.
ASSOCIATED CONDITIONS
Distichiasis lymphedema syndrome is
lymphedema associated with distichiasis (double
row of eyelashes).
Vertebral abnormalities, spinal arachnoid cysts,
hemangiomas, cleft palate, ptosis, short stature,
webbed neck, strabismus, thoracic duct
abnormalities, and microphthalmia.
Associated with yellow nail syndrome.
ASSOCIATED CONDITIONS
Other genetic syndromes and cutaneous
conditions associated with primary lymphedema
include the following:
Turner syndrome
Noonan syndrome
Klinefelter syndrome
Neurofibromatosis type 1
Hemangiomas
Xanthomatosis
Congenital absence of nails
SECONDARY LYMPHEDEMA
SECONDARY LYMPHEDEMA
Caused by an acquired defect in the lymphatic
system.
Associated with obesity, infection, neoplasm,
trauma, and therapeutic modalities.
SECONDARY LYMPHEDEMA
1.Filariasis
The most common cause of secondary
lymphedema.
Caused by a mosquito-borne nematode infection
with the parasite Wucheria bancrofti.
Commonly occurring in developing countries
around the world.
Results in permanent lymphedema of the limb.
SECONDARY LYMPHEDEMA
2. Malignancy and cancer treatment
Obstruction from metastatic cancer or primary
lymphoma or secondary to radical lymph node
dissection and excision.
The most commonly affected area is the axillary
region after mastectomy
Lymphedema can also be seen after regional
dissection of pelvic, para-aortic, and neck lymph
nodes.
SECONDARY LYMPHEDEMA
Other causes
Trauma
Varicose vein surgery
Congestive heart failure
Portal hypertension
Peripheral vascular surgery
Lipectomy
Burns
Burn scar excision
Insect bites
Extrinsic pressure
CLINICAL PRESENTATION
HISTORY
Chronic swelling of an extremity.
First noticed by the patient as an asymmetry or
increased circumference of an extremity.
As swelling slowly progresses, patients may have
difficulty fitting into clothing.
May cause fatigue due to the size and weight of the
extremity, embarrassment in public, and severe
impairment of daily activities.
Recurrent bacterial or fungal infections.
Fevers, chills, and generalized weakness.
History of recurrent episodes of cellulitis,
lymphangitis, fissuring, ulcerations, and/or verrucous
changes.
HISTORY
In primary lymphedema, the history of onset is more
typical. Associated with other anomalies and genetic
disorders.
In secondary lymphedema, the associated history is
based on the primary etiology.
If due to filariasis, the history should include travel or
habitation in an endemic area.
Other patients should have a clear history of a
neoplasm obstructing the lymphatic system, recurrent
episodes of lymphangitis and/or cellulitis, obesity,
trauma, or lymphedema resulting after surgery
and/or radiation therapy.
A recent history of varicose vein surgery also is
reported.
PHYSICAL EXAMINATION
The earliest symptom is nontender, pitting edema
progressing to a nonpitting one
Radial enlargement of the area.
Involvement of the distal extremities is followed
by proximal advancement.
Erythema and peau d'orange of skin.
Grade (Brunner)
Clinical features
Subclinical (latent)
There is excess interstitial fluid
and
histological abnormalities in
lymphatics
and lymph nodes, but no clinically
apparent lymphoedema
I
Oedema pits on pressure and
swelling
largely or completely disappears
on
elevation and bed rest
II
Oedema does not pit and does not
significantly reduce upon
elevation
III
Oedema is associated with
irreversible skin
changes, i.e. fibrosis, papillae
ELEPHANTIASIS NOSTRA VERRUCOSA
ENV is an area of cobble-stoned, hyperkeratotic,
papillomatous plaques most commonly seen on
the shins.
The plaques can be weepy or oozing a clear or
yellow fluid.
Fissuring, ulcerations, skin breakdown.
Superinfection is common and can manifest as
impetigo with yellow crusts.
EXAMINATION
A positive Stemmer sign (inability to pinch the
dorsal aspect of skin between the first and second
toes)
Patients with congenital lymphedema may also
present with recurrent cellulitis, papillomatosis,
large caliber leg veins, and upsloping "ski-jump"
toenails.
DIFFERENTIALS
Deep vein thrombosis
Hypoalbuminemia
Renal failure
Lipedema
Postoperative complications
Baker cyst
Idiopathic edema
Congestive heart failure
Idiopathic edema
Neurofibromatosis
Sclerema neonatorum
Features of lipoedema that help differentiate it from
lymphoedema
Occurs almost exclusively in women
Onset nearly always coincides with puberty
Nearly always bilateral and symmetrical
Involvement of trunk
The feet are not involved, leading to an inverse
shouldering effect at the malleoli
No pitting
No response to elevation or compression
No skin changes of lymphoedema (negative Stemmer's
sign)
MRI shows subcutanteous fat but no fluid
accumulation
WORKUP OF LYMPHEDEMA
Liver function, blood urea nitrogen
(BUN)/creatinine levels, and urinalysis results
should be checked if a renal or hepatic etiology is
suspected.
Specific markers should be checked if a neoplasm
is suspected.
CBC with differential should be checked if an
infectious etiology is being considered.
An indication for CT scanning or MRI is suspicion
of malignancy.
MRI is useful to show lymph trunk anatomy and
causes of obstructive secondary lymphedema.
Ultrasonography to evaluate the lymphatic and
venous systems.
Lymphangiography is now rarely used because of
the potential adverse effects.
Fluorescence microlymphography demonstrates a
lack of microlymphatics.
Lymphoscintigraphy.
TREATMENT OF LYMPHEDEMA
The goal is to restore function, reduce physical
and psychologic suffering, and prevent the
development of infection.
Initiate therapy as early as possible before
extensive, irreversible fibrosclerotic changes
occur in the interstitium.
Strict compliance is essential.
The majority of compliant patients can be treated
successfully with conservative measures
1.HYGIENE AND SKIN CARE
Appropriate skin care to prevent recurrent
cellulitis or lymphangitis.
Meticulous hygiene to remove keratinous debris
and bacteria.
Cleanse the skin regularly and dry thoroughly.
Regular inspection is necessary to identify any
open wounds or developing cellulitis.
2.PHYSICAL THERAPY AND COMPRESSION
The first-line treatment.
Aimed at improving lymphedema with manual
lymphatic drainage, massage, and exercise.
It advocates the use of compression stockings (at
a minimum of 40 mm Hg), multilayer bandaging,
or pneumatic pumps.
Encourage patients to lose weight, avoid minor
trauma, and avoid constrictive clothing that
might have a tourniquet effect.
Encourage elevation of the affected extremity
whenever possible, particularly at night.
3. SURGERY
Surgical treatment is palliative, not curative,
and it does not obviate the need for continued
medical therapy.
Surgical treatment is reserved for patients who
do not improve with conservative measures or for
cases in which the extremity is so large that it
impairs daily activities and prevents successful
conservative management.
Surgical procedures are classified as physiologic
or excisional.
PHYSIOLOGIC SURGERY
Physiologic procedures attempt to improve
lymphatic drainage. Multiple techniques have
been described, including omental transposition,
buried dermal flaps, enteromesenteric bridging,
lymphangioplasty, and microvascular
lympholymphatic anastomosis.
EXCISIONAL SURGERY
Excisional techniques remove the affected tissues,
thus reducing the lymphedema-related load.
The Charles procedure is a radical excisional
technique. This procedure involves the total excision
of all skin and subcutaneous tissue from the affected
extremity. The underlying fascia is then grafted,
using the skin that has been excised. This technique
is extreme and is reserved for only the most severe
cases.
Complications include ulceration, hyperkeratosis,
keloid formation, hyperpigmentation, weeping
dermatitis, and severe cosmetic deformity.
A variant of the Charles procedure, total superficial
lymphangiectomy, involves debulking of the entire
limb.
COMPRESSION THERAPY
Patients should use compression garments
continuously during the day.
They should also have graduated compression that
increases from distal to proximal on the affected
extremity.
Intermittent pneumatic pump compression therapy
provides sequential, active compression from distal to
proximal, effectively milking the lymph from the
extremity.
This treatment is most appropriately used prior to
fibrosclerotic evolution, which it assists in preventing.
Contraindications to intermittent pneumatic pump
compression therapy include congestive heart failure,
deep vein thrombosis, and active infection.
MLD
Manual lymphatic drainage according to the
Vodder and/or Leduc techniques.
Compression garments are essential between
treatments.
Manual massage of the affected extremity; this
recruits collateral vessels, allowing the
accumulated lymph to be drained into
neighboring regions with normally functioning
lymphatics.
PHARMACOLOGIC THERAPY
Cellulitis
At the earliest signs of infection, institute topical or
systemic antifungal or antimicrobial therapy to prevent the
development of sepsis.
Filariasis
Filariasis has been treated with DEC and albendazole
Benzopyrones
These drugs bind to accumulated interstitial proteins,
inducing macrophage phagocytosis and proteolysis. The
resulting protein fragments pass more readily into the
venous capillaries and are removed by the vascular system.
The benzopyrones aid in decreasing excess edematous fluid,
softening the limb, decreasing skin temperature, and
reducing the number of secondary infections. Of note,
however, is that hepatotoxicity has been associated with
coumarin therapy.
PHARMACOLOGIC THERAPY
Retinoids
Help normalize keratinization and decrease
inflammatory and fibrotic changes.
Topical agents
Topical emollients and keratolytics have been
recommended to improve secondary epidermal
changes.
What every patient with lymphoedema should receive
An explanation of why the limb is swollen and the
underlying cause
Guidance on skin hygiene and care and the avoidance of
acute infective episodes
Anti-fungal prophylactic therapy to prevent athlete's foot
Rapid access to antibiotic therapy if necessary, hospital
admission for acute infective episodes
Appropriate instructions regarding exercise therapy
Manual lymphatic drainage (MLD)
Multilayer lymphoedema bandaging (MLLB)
Compression garments and, if appropriate, specialised
footwear
Advice on diet
Access to support services and networks
This post was last modified on 08 April 2022